Matthew Ung

Matthew Ung is currently the Associate Director and Principal Scientist at Vor Bio, where Matthew leverages single-cell multiomics technology to enhance the eHSC platform and identify novel targets for acute myeloid leukemia. Matthew also works on maintaining a democratized data science ecosystem for Research to accelerate discovery. Prior to Vor Bio, Matthew worked at Immuneering Corporation as the Senior Director of Single Cell Technologies and as Director and Associate Director of Systems Pharmacology. Matthew completed their Ph.D. and M.S. at the Geisel School of Medicine at Dartmouth in Molecular and Systems Biology and Quantitative Biomedical Sciences, respectively, and their B.S. in Microbiology, Immunology, & Molecular Genetics at UCLA.